Please login to the form below

Not currently logged in
Email:
Password:

Portfolio Analysis

This page shows the latest Portfolio Analysis news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Finance and investment

  • Deal Watch March 2017 Deal Watch March 2017

    Sartorius. Acquisition. Platform, instrumentation, software and reagents for real-time live cell analysis. ... 320. Neurovance. Otsuka. Acquisition. Portfolio, including centanafadine in ADHD, with phase II complete.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics